Top Markets
Coin of the day
Oragenics, Inc. Oragenics, Inc.

Oragenics, Inc.

OGEN
Clasificación en acciones #36713
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on... Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed at preventing dental cavities. Strategic alliances are also a part of its operations. This includes a licensing deal with Noachis Terra Inc. for patents and biological resources related to pre-fusion coronavirus spike proteins. Additionally, Oragenics is collaborating with Precigen, Inc. and ILH Holdings, Inc. on the advancement and market introduction of MU1140 and its associated compounds. Established in 1996, the company, formerly known as Oragen, Inc., maintains its headquarters in Tampa, Florida.
Precio por acción
$0.5301
Última sincronización: 2026-08-14
Capitalización bursátil
$2.39M
Cambio (1 día)
0.00%
Cambio (1 año)
-53.90%
País
US
Comercio Oragenics, Inc. (OGEN)

Categoría

Historial del precio de la acción de Oragenics, Inc. (OGEN)
Precio más alto de cierre: $0.53 el 2026-08-01

Precio más bajo de cierre: $1.08M el 2003-07-01
Historial del precio de la acción de Oragenics, Inc. desde 2003 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -2.01%
2025 -92.01%
2024 -92.61%
2023 -50.48%
2022 -65.96%
2021 7.57%
2020 -16.69%
2019 -44.73%
2018 -66.89%
2017 -49.72%
2016 -58.32%
2015 53.42%
2014 -69.17%
2013 35.84%
2012 46.62%
2011 -58.54%
2010 -35.31%
2009 -12.86%
2008 -26.00%
2007 -61.09%
2006 110.38%
2005 -85.73%
2004 -5.16%
2003 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE